相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
- 库存:
货期:询盘
- 供应商:
MedChemExpress LLC
- CAS号:
2709045-53-2
- 规格:
询盘
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
AKT-IN-9
CAS No. : 2709045-53-2
MCE 国际站:AKT-IN-9
产品活性:AKT-IN-9 是一种有效的 AKT 抑制剂。蛋白激酶 B (PKB,也称为 AKT) 是细胞中 PI3K/AKT/mTOR 信号传导的核心,其功能对细胞生长、存活、分化和代谢很重要。AKT-IN-9 具有研究乳腺癌和前列腺癌的潜力 (摘自专利 WO2021185238A1,化合物 1)。
研究领域:PI3K/Akt/mTOR
作用靶点:Akt
相关产品:Deferoxamine mesylate | MK-2206 dihydrochloride | SC79 | Yoda 1 | Afatinib | Capivasertib | Ipatasertib | Honokiol | Chloramphenicol | Oridonin | AKT inhibitor VIII | Artemisinin | Isoginkgetin | GSK-690693 | α-Linolenic acid | Guggulsterone | Recilisib | Scutellarin | Miransertib | Perifosine | Afuresertib | PRE-084 hydrochloride | Uprosertib | Triciribine | (Z)-Guggulsterone | Miltefosine | AKT Kinase Inhibitor hydrochloride | Deguelin | SU6656
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验and p53. Akt is also major mediator of cell survival by directly inhibiting different pro-apoptotic signals such as Bad and the Forkhead family of transcription factors, or indirectly by modulating two central regulators of cell death such as p53 and NF-£
and p53. Akt is also major mediator of cell survival by directly inhibiting different pro-apoptotic signals such as Bad and the Forkhead family of transcription factors, or indirectly by modulating two central regulators of cell death such as p53 and NF-£
剂量-时间依赖的抑制HepG2和Hep3B细胞生长。饱和效应浓度的 LY294002和RAPA作用24小时后,HepG2和Hep3B细胞均呈现明显的G0/G1期阻滞,处于S期的细胞比例较对照组显著减少 (P 结论:(1)HepG2和Hep3B细胞存在PI3K/Akt/mTOR信号通路的组成性激活;(2)LY294002和RAPA能有效阻断HepG2和 Hep3B细胞PI3K/Akt/mTOR信号通路,抑制HCC细胞的生长增殖,诱导细胞周期阻滞,促进细胞凋亡,且阻断效应与HCC细胞P53的表达
技术资料暂无技术资料 索取技术资料

















